Answers are grounded in this paper and cite their sources.
This work identifies and engineers proteases to enhance specificity and performance in human cells, suggesting new therapeutic applications.
Efficiency and substrate specificity of proteases in the Potyviridae family have not been comprehensively profiled. Here we develop a model that learns co-evolutionary features to accurately predict and experimentally validate protease performance at single amino-acid resolution. We identify and engineer several proteases that perform better than the commercially available tobacco etch virus protease. To demonstrate the resolving power of our methods, we engineer protease crosstalk to selectively trigger a synthetic cell-death program in human cells.
No takes yet. Share an insight, caveat, or question.
Suan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: